Vivacelle Bio, Inc.
- Biotech or pharma, therapeutic R&D
505(b)2-Ph3 clinical stage company focused on treating septic shock, multiple organ dysfunction syndrome, hemorrhagic shock & reperfusion injury by addressing conditions related to lack of blood supply including absolute hypovolemia & relative hypovolemia
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}